Author(s): Nirma Chavda, Suresh Kumar

Email(s): jdrsuresh@gmail.com

DOI: 10.52711/2231-5675.2021.00040   

Address: Nirma Chavda, Dr. Suresh Kumar*
B. Pharmacy College, Rampura, Kakanpur, Gujarat.
*Corresponding Author

Published In:   Volume - 11,      Issue - 3,     Year - 2021


ABSTRACT:
The literature survey explains that there is not any stability indicating method reportedly for combination of Azelnidipine and Telmisartan till date. Validation and development of stability indicating analytical methods is possible as per ICH Guidelines. There are several of Spectroscopic methods such as Ultraviolet Spectroscopy, Mass spectroscopy, infrared spectroscopy, Nuclear magnetic resonance spectroscopy and Chromatographic methods such as High performance liquid chromatography, Thin layer Chromatography, High Performance thin layer chromatography, Gas chromatography and Ultra performance liquid chromatography etc. used for stability indicating method development and validation.


Cite this article:
Nirma Chavda, Suresh Kumar. A Review article on Analytical Method Development for the combination of Azelnidipine and Telmisartan. Asian Journal of Pharmaceutical Analysis. 2021; 11(3):227-4. doi: 10.52711/2231-5675.2021.00040

Cite(Electronic):
Nirma Chavda, Suresh Kumar. A Review article on Analytical Method Development for the combination of Azelnidipine and Telmisartan. Asian Journal of Pharmaceutical Analysis. 2021; 11(3):227-4. doi: 10.52711/2231-5675.2021.00040   Available on: https://ajpaonline.com/AbstractView.aspx?PID=2021-11-3-10


REFERENCES:
1.    William AP. Goodman and Gilman’s. The Pharmacological Basis of Therapeutics. 11th Edn. Tata Mac Graw Hill Publishing, 2008; pp 488-492.
2.    Gandhimathi M. Anandkumar K. Cheriyan A. and Ravi T.K. Ind. J. pharm. 2003; 65(6): 530-531.
3.    Praful Sahare, Amit Nayak, Alok Pal Jain, HarikishorBarange. Development of Validated Analytical Methods and Stability Indicating studies for Pharmaceutical Formulation. Asian J. Pharm. Ana. 2021; 11(1): 29-37. doi: 10.5958/2231-5675.2021.00006.5
4.    Nash R.A. Watcher A.H. Pharmaceutical Process Validation. Marcel Dekker Inc. New York: 2003; pp 507-522.
5.    ICHQ2(A): Validation of analytical procedures. Text and Methodology. ICH Harmonized Tripartite Guidelines; 1996.
6.    Kirthi A, Shanmugam R, Mohana Lakshmi S, Ashok Kumar CK, Padmini K, Shanti Prathyusha M, Shilpa V. Analytical Method Development and Validation of a Stability-indicating RP-HPLC Method for the Analysis of Danazol in Pharmaceutical Dosage Form. Asian J. Pharm. Ana. 2016; 6(4): 227-234.
7.    Hamid Khan, Javed Ali. UHPLC: Applications in Pharmaceutical Analysis. Asian J. Pharm. Ana. 2017; 7(2): 124-131. doi: 10.5958/2231-5675.2017.00020.5
8.    Cartenson JT. Swarbirck J. Solution kinetics- Drug stability principles and practice. 2nd Edn. Marcel Dekker series. 1995; pp 17-9.
9.    Q1A (R2): Stability Testing of New Drugs and Products. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. Ich Harmonised Tripartite Guideline. 2003; 1-18.
10.    Amitkumar J. Vyas, Dhruvanshi A. Gol, Ajay I. Patel, Ashok B. Patel, Nilesh K. Patel, Alpesh Chudasama. A Stress Degradation Kinetic Study of Tadalafil Bulk and Tablet Dosage Form by UV Spectrophotometry. Asian J. Pharm. Ana. 2020; 10(4): 177-181. doi: 10.5958/2231-5675.2020.00032.0
11.    Sushil D. Patil, Sunil V. Amurutkar, C.D. Upasani. Development and Validation of Stability Indicating RP-HPLC Method for Empagliflozin. Asian J. Pharm. Ana. 2016; 6(4): 201-206. doi: 10.5958/2231-5675.2016.00030.2
12.    Shanthi Diraviyam Shanmugakumar, Anjali, Nasreen Begum, Boga Uday. A Novel RP-HPLC Method for Determination of Esomeprazole in Pharmaceutical Dosage Forms in Human Plasma: A Pilot Stress Degradation Study. Asian J. Pharm. Ana. 2021; 11(1): 9-16. doi: Esomeprazole, forced degradation, High-performance liquid chromatography, Human Plasma.
13.    https://pubchem.ncbi.nlm.nih.gov/compound/Telmisartan#section=Color-Form
14.    B. Bhavya, P. Nagaraju, V. Mounika, G. Indira Priyadarshini. Stability Indicating RP-HPLC Method Development and Validation for Simultaneous Estimation of Albendazole and Ivermectin in Pharmaceutical Dosage form. Asian J. Pharm. Ana. 2017; 7(1): 6-14. doi: 10.5958/2231-5675.2017.00002.3
15.    Prasenjit Mondal, Venu Kola. A New Stability Indicating Validated RP-HPLC Method for Simultaneous Estimation of Escitalopram and Clonazepam in Bulk and Tablet Dosage Form. doi: 10.5958/2231-5675.2019.00032.2
16.    Hamid Khan. UHPLC/Q-TOF-MS Method for Determination of Antihypertensive Drugs and its Application to Pharmacokinetic Study. Asian J. Pharm. Ana. 2021; 11(1):22-26. doi: 10.5958/2231-5675.2021.00004.1
17.    Chen B. Clinical use of azelnidipine in the treatment of hypertension in Chinese pateints. Therapeutics and clinical risk management. 11 (2015); 309-318.
18.    Ankita B. Tayade, Amod S. Patil, Priti Jain, Sanjay J. Surana, Atul A. Shirkhedkar. Inclusive Review on Analytical and Bioanalytical Profile of Nifedipine. Asian J. Pharm. Ana. 2019; 9(3): 177-190. doi: 10.5958/2231-5675.2019.00031.0
19.    https://pubchem.ncbi.nlm.nih.gov/compound/Azelnidipine
20.    ICH guidelines. Validation of Analytical Procedure: Methodology Q2B. ICH Harmonized Tripartite Guidelines; 1996.
21.    Kholkar S.M. Basic concepts of analytical chemistry. New age International Ltd. Publishers; New delhi: 1998; pp 178-179.
22.    http://flipper.diff.org/app/items/info/4230
23. https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020850s022s023lbl.pdf
24.    N. Vanaja, Ch. Preethi, S.Y. Manjunath, Krishanu Pal. Method Development and Validation for Simultaneous Estimation of Telmisartan and Chlorthalidone by RP-HPLC in Pharmaceutical Dosage Form. Asian J. Pharm. Ana. 5(4): October- December, 2015; Page 171-177. doi: 10.5958/2231-5675.2015.00027.7
25.    Rele R. V, Patil S.P. UV Spectrophotometric method for estimation of Azelnidipine from bulk drug and pharmaceutical formulation. Asian J. Research Chem2010; 3(4): 1077-1079.
26.    D. Prabhakar, J. Shreekanth, K.N. Jatveera. Method development and validation of Azelnidipine by RP-HPLC. International Journal OfChemTech Research. 2017; 10(10): 418-423.
27.    Akhsay R Rane, Dr Sunil K Mahajan. Validation and forced stability indicating HPTLC method for determination of Azelnidipine. World Journal of Pharmaceutical Research. 2016; vol 5, 1053-1062.
28.    Jenisha Modi, Shivangi K Patel. Stability indicating analytical method development and validation for estimation of Azelnidipine. World Journal of Pharmaceutical Research. 2016; vol 5, 831-847.
29.    S. Junehha, P. Venkateshvarlu, P.S.S Prasad. Sensitive analysis of Azelnidipine and relative derivatives in human plasma by ultra performance liquid chromatography-tandam mass spectroscopy. Asian Journal of Chemistry. 2013; vol 25, 10319-10321.
30.    Ravindra Babu Ganduri, JaychandraRaddy, HimabinduVirumindi, Ramprakash. Stability indicating liquid chromatography method for the simultaneous determination of Olmesartan Medoxomil and Azelnidipine in combined tablet dosage form. International Journal of Pharma Sciences and Research.2014; vol 5, 0975-94.
31.    Alaa El Sayed Ahmed Amin, Mounir Zaky Saad, Mohamed Aly Amin Ahmed. Simultaneous Determination of Azelnidipine and Olmesartan Medoxomil in Pharmaceutical Dosage Forms by UFLC Method. Journal of PharmaSciTech. 2016; vol 6.
32.    NilamPatela, Jayvadan K. Patelb. Simultaneous determination of Olmesartan Medoximil and Azelnidipine by first derivative spectroscopic method. Scholars Research Library.2012; 4 (4): 1080-1084.
33.    Kishanta Kumar Pradhan, Uma Shankar Mishra, Aurobindo Sahoo, KanhuCharanaSahu, Debananda Mishra, Ranjit Dash. Method development and validation of telmisartan in bulk and pharmaceutical dosage forms by UV spectrophotometric method. International Journal of Research in Pharmaceutical Sciences. 2(4), 2011; 526-530.
34.    M. Lakshmi Surekha, G. Kumara Swamy, G. Lakshmi Ashwini. Development and Validation of RP - HPLC method for the estimation of Telmisartan in bulk and tablet dosage Form. International Journal of Drug Development and Research. 2012; vol 4, pp 0975-9344.
35.    Chitra Prabhu, Ganesa Sundararajan Subramanian, Arumugam Karthik, Suvarna Kini, Mallayasamy Surulivel Rajan, Nayanabhirama Udupa. Determination of Telmisartan by HPTLC – A Stability Indicating Assay. Journal of Planar Chromatography. 20 (2007); 6.
36.    Lalit Thakare, Sufiyan Ahmad. Development and validation UV method for Telmisartan and cilnidipine in its bulk formulation. Indo American Journal of Pharmaceutical Research. 2007; vol 5.
37.    Reema H. Rupareliya and Hitendra S. Joshi. Stability Indicating Simultaneous Validation of Telmisartan and Cilnidipine with Forced Degradation Behavior Study by RP-HPLC in Tablet Dosage Form. Hindawi Publishing Corporation ISRN Chromatography.
38.    A.R. Chabukswar1, S.C. Jagdale1, S.V. Kumbhar1, D.J. Desai1, B.S. Kuchekar1, P.D. Lokhande. HPLC Method Development for Telmisartan and Amlodipine. Research J. Pharm. and Tech.3(4): Oct.-Dec.2010; Page 1227-1230.
39.    Santosh Kumar M, Venkanteshwar Rao Jupally. Development and validation of A Stability indicating RP-HPLC method for simultaneous determination of Telmisartan and Amlodipine in combined dosage form. Asian Journal of Pharamaceutical and Clinical Research. Vol 7, Issue 1, 2014.
40.    Kaliappan Ilango1 and Pushpangadhan S. Shiji Kumar. Development and Validation of Stability Indicating HPTLC and HPLC Methods for Simultaneous Determination of Telmisartan and Atorvastatin in Their Formulation. Hindawi Publishing Corporation Journal of Chemistry.Volume 2013.
41.    P.Gayathri1, K.N. Jayaveera, Sasikiran Goud, N. Sravan Reddy. Analytical method development and validation of Simultaneous estimation of Metformin and Telmisartan in bulk and pharamceutical dosage form by RP-HPLC method. World Journal OfPharamcy and Pharmaceutical Sciences.Volume 4, Issue 4,753-762.
42.    A. Shashi Kumari, P. Sunil Kumar Chaitanya, G. Rohini Reddy and Jomol Joseph P. Naga Haritha. Development and validation of an analytical method for simultaneousestimation of telmisartan and ramipril using reverse phase HPLC in bulk and dosage form. Pelagia Research Library, Der Pharmacia Sinica.2014; 5(6): 79-85.
43.    Binalben S. Patel, Dr. Shailesh V. Luhar, Dr. Sachin B. Narkhede. Analytical method development and validation of Telmisartan, Cilnidipine and Metoprolol succcinate in pharmaceutical dosage from. European Journal of Biomedical and Pharmaceutical Sciences.2018; Volume 5, Issue 5, 287-306.
44.    RlcSasidhari, S. Vidyadharai, B. Deepti, K. Tejaswi and J. Suhasini. Development and Validation of RP - HPLC Method for the Simultaneous Determination of Hydrochlorothiazide, Amlodipine Besylate and Telmisartan in Bulk and Pharmaceutical Formulation. Oriental Journal of Chemistry.2014; Vol. 30, No. (4): Pg. 1815-1822.
45.    Bhoomi D. Patel, Ankit Chaudhary, Sudhir Gami. Development and validation RP-HPLC methodfor simultaneous estimation of Chlorthalidone, Telmisartan and Benidipine HCl in their Combined Dosage Form. Journal of Emerging Technologies and Innovative Research. March 2019; Volume 6.
46.    N. Vanaja, Ch. Preethi, Dr. S.Y. Manjunath, Krishanu Pal. Development and validation RP-HPLCmethod for simultaneous estimation of Chlorthalidone, and Telmisartan in their Combined Dosage Form. Asian Pharma Press. 2015; Vol. 5: Issue 4, Pg 171-177.
47.    Shah Binal B, Patel Bhoomi B, Gohil Kirtan N, Patel Piyush M. Difference SpectrophotometricMethod Development and Validation for Simultaneous Estimation of Rosuvastatin Calcium andTelmisartan in Bulk and Combined Dosage Form. International Journal of Research in Pharmacyand Science. 2012; 2(2),106-114.
48.    Jain Nilesh, Sharma Bhupendra Kumar, Jain Ruchi, Jain Deepak Kumar andJain Surendra. RP-HPLC Method Development and Validation for Quantitative Estimation of Metoprolol Succinate and Telmisartan in Bulk Drug and Their Dosage Forms. Journal of Pharmaceutical and Biomedical Sciences.2012;24 (24); 102-106.
49.    Aashka Joshi1, Dr. C. N. Patel. Stability indicating assay method development and validation ofnebivolol and telmisartan in pharmaceutical dosage forms. World Journal of Pharmaceutical Research. Volume 7, Issue 16, 1006-1016.
50.    Dharmendra Damor, Karan Mittal, Bhoomi Patel, RajashreeMashru. Method development andvalidation of simultineius estimation of Cilostazol and Telmisartan. Research Journal of Pharmaceutical Analysis. 2015; vol 4.
51.    Zeel T. Doshi, Jignesh S. Shah1, Dilip G. Maheshwari. Development and Validation RP-HPLC Method for Simultaneous Estimation of Telmisartan and Nifedipine in Synthetic Mixture. AsianJournal of Pharmaceutical Technology and Innovation. 04 (18); 2016; 01 -10.
52.    Dhanalakshmi K, Tatineni Vasuki, Nagarjuna reddy, Jotheiswari D. Analytical method development and validation of Telmisartan and hydrochlorothaize in dissolution by RP-HPLC. International Journal of Biological and Pharmaceutical Research. 2013; 4(3): 200-211.
53.    Jayesh G. Panchal, Ravindra V. Patel, Bhoomika R. Mistry, Shobhana K. Menon. Development and Validation of Reversed-Phase LC Method for Simultaneous Determination Telmisartan, Amlodipine and Their Degradation Products in Fixed Dose Combination Tablets.Euracian Journal of Pharmaceutical Analysis. 7(1): 28-42, 2012.
54.    Hassan A. Alhazmi, Ahmed M. Alnami, Mohammed A. A. Arishi, Raad K. Alameer, Mohammed Al Bratty, Zia ur Rehman, Sadique A. Javed, smail A. Arbab. A Fast and Validated Reversed-Phase HPLC Method for Simultaneous Determination of Simvastatin, Atorvastatin, Telmisartan and Irbesartan in Bulk Drugs and Tablet Formulations. Scientia Pharmaceutia. 2018; 86,1.
55.    Jenisha Modi, Shivangi K Patel. Stability indicating analytical method development and validation for estimation of Azelnidipine. World Journal of Pharmaceutical Research.2016; vol 5, 831-847.

Recomonded Articles:

Author(s): K. Pramod, Shahid H. Ansari, Javed Ali

DOI:         Access: Open Access Read More

Author(s): Kirthi A, Shanmugam R, Mohana Lakshmi S , Ashok Kumar CK, Padmini K, Shanti Prathyusha M, Shilpa V

DOI:         Access: Open Access Read More

Author(s): Hamid Khan, Javed Ali

DOI: 10.5958/2231-5675.2017.00020.5         Access: Open Access Read More

Author(s): Shobha Rani G, Lohita M, Jaya Preethi P, Madhavi R, Sunisitha B, Mounika D

DOI:         Access: Open Access Read More

Author(s): Santosh Gada, Anand Kumar Y, Saritha, C. Mallikarjuna Setty

DOI: 10.5958/2231-5675.2018.00036.4         Access: Open Access Read More

Author(s): Mansi J. Chaudhari, Suraj R. Chaudhari, Shailesh S. Chalikwar, Atul A. Shirkhedkar

DOI: 10.5958/2231-5675.2018.00008.X         Access: Open Access Read More

Author(s): Sri Lakshmi D, Jane T Jacob, Srinivasa Sastry D, Satyanarayana D

DOI: 10.5958/2231-5675.2017.00005.9         Access: Open Access Read More

Author(s): Khushboo Patel*, Dhara Patel, Jaya Dwivedi, Priyanka Newal, Dhananjay Meshram

DOI: 10.5958/2231-5675.2017.00039.4         Access: Open Access Read More

Author(s): B. Thangabalan, M. Salomi, N. Sunitha, S. Manohar Babu

DOI:         Access: Open Access Read More

Author(s): Paras Virani, Rajanit Sojitra, Hasumati Raj, Vineet Jain

DOI: 10.5958/2231-5675.2015.00025.3         Access: Open Access Read More

Asian Journal of Pharmaceutical Analysis (AJPA) is an international, peer-reviewed journal, devoted to pharmaceutical analysis...... Read more >>>

RNI: Not Available                     
DOI: 10.5958/2231–5675 

Popular Articles


Recent Articles




Tags